Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT07412769
Recruiting Observational

ASMact: Study on Management of Bronchial Asthma

NCT07412769 · tracked via the Priya Life Science Italy tracker
Sponsor
Meyer Children's Hospital IRCCS
Phase
Observational
Started
2025-11-05
Last updated
2026-02-17

Condition(s) studied

Asthma AcuteAsthma ChildhoodAsthma in ChildrenAsthma Crisis

Study summary

Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.

Eligibility

Sex
ALL
Min age
6 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 6 and 17 years * Presentation to the emergency department with a diagnosis of acute asthma exacerbation * Evaluation in the emergency department of one of the participating centers during the study periods Exclusion Criteria: * Age \< 6 years or \> 17 years * Diagnosis other than acute asthma exacerbation * Incomplete or missing clinical data * Patients transferred from other hospitals already treated for the same episode * history of allergy to any drugs used in the protocol

Primary outcome measure(s)

  • Change in the number of correctly reported diagnoses before and after intervention — Pre-intervention and through study completion, an average of 9 months
    Assessment of adherence to guideline-based diagnostic and therapeutic management of pediatric patients presenting with acute asthma exacerbations in the emergency department.
  • Percentage of patients with correct timing, dosage, and method of drug administration before and after intervention — Pre-intervention and through study completion, an average of 9 months
  • Percentage of patients with correct follow-up at discharge — Pre-intervention and through study completion, an average of 9 months
  • Percentage of patients in whom additional drugs are used in refractory cases — Pre-intervention and through study completion, an average of 9 months
  • Percentage of patients with correct therapy at discharge — Pre-intervention and through study completion, an average of 9 months

Trial sites (2)

FacilityCityRegionStatus
Arcispedale S. Anna Ferrara FE Recruiting
Meyer Children's Hospital IRCCS, Firenze Florence Italy Recruiting

More Meyer Children's Hospital IRCCS trials in Italy

Psychotropic-Drug-induced QT Prolongation and ECG Monitoring in the Pediatric Population Recruiting
Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age Recruiting
Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis Recruiting
SLIT ABS: Study on Patients With Autoimmune Podocytopathy Recruiting
Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07412769 on ClinicalTrials.gov ↗ ← All trials in Italy